FXR knockout mice show impaired glucose tolerance and reduced insulin sensitivity, suggesting that BA activation of FXR may improve IR by inhibiting hepatic SREBP-1c expression and/or modulating glucose-induced lipogenesis (Lefebvre et al., 2009). Here, NR1H4 is linked to Impaired glucose tolerance.